AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 1-25/69
FASTER ENGRAFTMENT OF PERIPHERAL-BLOOD PROGENITOR CELLS COMPARED TO BONE-MARROW FROM UNRELATED DONORS
Authors: RINGDEN O HAGGLUND H RUNDE V BASU O KROSCHINSKY F STOCKSCHLADER M POTTER MN
Citation: O. Ringden et al., FASTER ENGRAFTMENT OF PERIPHERAL-BLOOD PROGENITOR CELLS COMPARED TO BONE-MARROW FROM UNRELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 81-84
BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AS HIGH-DOSE CONDITIONING THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMA AND PRIOR DOSE-LIMITING RADIATION-THERAPY
Authors: KROGER N HOFFKNECHT M HANEL M KRUGER W ZELLER W STOCKSCHLADER M DEWIT M WEH HJ KABISCH H ERTTMANN R ZANDER AR
Citation: N. Kroger et al., BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AS HIGH-DOSE CONDITIONING THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMA AND PRIOR DOSE-LIMITING RADIATION-THERAPY, Bone marrow transplantation, 21(12), 1998, pp. 1171-1175
LONG-TERM DISEASE-FREE SURVIVAL OF PATIENTS WITH ADVANCED MANTLE-CELLLYMPHOMA FOLLOWING HIGH-DOSE CHEMOTHERAPY
Authors: KROGER N HOFFKNECHT M DREGER P KRUGER W ZELLER W KRULL A STOCKSCHLADER M BITTNER S WEH HJ ZANDER AR
Citation: N. Kroger et al., LONG-TERM DISEASE-FREE SURVIVAL OF PATIENTS WITH ADVANCED MANTLE-CELLLYMPHOMA FOLLOWING HIGH-DOSE CHEMOTHERAPY, Bone marrow transplantation, 21(1), 1998, pp. 55-57
IMPROVED RETROVIRAL TRANSDUCTION OF HUMAN T-CELLS
Authors: STOCKSCHLADER M HAISS M EXNER S FEHSE B ZANDER A RUGER R KOCH S METTELSMANN R FINKE J
Citation: M. Stockschlader et al., IMPROVED RETROVIRAL TRANSDUCTION OF HUMAN T-CELLS, Bone marrow transplantation, 21, 1998, pp. 382-382
SUICIDE GENE-TRANSFER INTO HUMAN T-CELLS USING RETROVIRAL VECTORS
Authors: FEHSE B LI ZX SCHADE UM UHDE A FEHSE N STOCKSCHLADER M ZANDER AR
Citation: B. Fehse et al., SUICIDE GENE-TRANSFER INTO HUMAN T-CELLS USING RETROVIRAL VECTORS, Bone marrow transplantation, 21, 1998, pp. 383-383
HIGHLY-EFFICIENT GENE-TRANSFER WITH RETROVIRAL VECTORS INTO HUMAN T-LYMPHOCYTES ON FIBRONECTIN
Authors: FEHSE B SCHADE UM LI ZX UHDE A KOCH S GOLLER B RUGER R FEHSE N STOCKSCHLADER M ZANDER AR
Citation: B. Fehse et al., HIGHLY-EFFICIENT GENE-TRANSFER WITH RETROVIRAL VECTORS INTO HUMAN T-LYMPHOCYTES ON FIBRONECTIN, British Journal of Haematology, 102(2), 1998, pp. 566-574
HIGH-DOSE CHEMOTHERAPY WITH BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDEAS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: ZANDER AR BERGER C KROGER N STOCKSCHLADER M KRUGER W HORSTMANN M GRIMM J ZELLER W KABISCH H ERTTMANN R SCHONROCK P KUSE R BRAUMANN D ILLIGER HJ FIEDLER W DEWITT M HOSSFELD KD WEH HJ
Citation: Ar. Zander et al., HIGH-DOSE CHEMOTHERAPY WITH BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDEAS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION, Clinical cancer research, 3(12), 1997, pp. 2671-2675
SELECTIVE IMMUNOAFFINITY-BASED ENRICHMENT OF CD34(-AFFINITY NERVE GROWTH-FACTOR RECEPTOR (DELTA-LNGFR) GENE() CELLS TRANSDUCED WITH RETROVIRAL VECTORS CONTAINING AN INTRACYTOPLASMATICALLY TRUNCATED VERSION OF THE HUMAN LOW)
Authors: FEHSE B UHDE A FEHSE N ECKERT HG CLAUSEN J RUGER R KOCH S OSTERTAG W ZANDER AR STOCKSCHLADER M
Citation: B. Fehse et al., SELECTIVE IMMUNOAFFINITY-BASED ENRICHMENT OF CD34(-AFFINITY NERVE GROWTH-FACTOR RECEPTOR (DELTA-LNGFR) GENE() CELLS TRANSDUCED WITH RETROVIRAL VECTORS CONTAINING AN INTRACYTOPLASMATICALLY TRUNCATED VERSION OF THE HUMAN LOW), Human gene therapy, 8(15), 1997, pp. 1815-1824
ALLOGENEIC TRANSPLANTATION WITH CD34(-SELECTED CELLS())
Authors: STOCKSCHLADER M HASSAN HT ZELLER W KRUGER W CLAUSEN J LOLIGER C DIECK AT KROGER N LINK H KABISCH H HOSSFELD DK ZANDER A
Citation: M. Stockschlader et al., ALLOGENEIC TRANSPLANTATION WITH CD34(-SELECTED CELLS()), Leukemia & lymphoma, 25(1-2), 1997, pp. 145-151
ANTIMYCOTIC THERAPY WITH LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: KRUGER W STOCKSCHLADER M SOBOTTKA I BETKER R DEWIT M KROGER N GRIMM J ARLAND M FIEDLER W ERTTMANN R ZANDER AR
Citation: W. Kruger et al., ANTIMYCOTIC THERAPY WITH LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Leukemia & lymphoma, 24(5-6), 1997, pp. 491-499
FACTORS INFLUENCING HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE
Authors: HASSAN HT KROG C STOCKSCHLADER M ZELLER W KRUGER W ERTTMANN R ZANDER AR
Citation: Ht. Hassan et al., FACTORS INFLUENCING HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE, Supportive care in cancer, 5(4), 1997, pp. 299-306
HIGH EFFICIENT RETROVIRAL VECTOR-MEDIATED GENE-TRANSFER INTO HUMAN T-LYMPHOCYTES
Authors: LI ZX SCHADE U FEHSE B STOCKSCHLADER M UHDE A FEHSE N ZANDER AR
Citation: Zx. Li et al., HIGH EFFICIENT RETROVIRAL VECTOR-MEDIATED GENE-TRANSFER INTO HUMAN T-LYMPHOCYTES, Cancer gene therapy, 4(5), 1997, pp. 327-327
NONTRANSFERRIN-BOUND IRON IN SERUM OF PATIENTS RECEIVING BONE-MARROW TRANSPLANTS
Authors: DURKEN M NIELSEN P KNOBEL S FINCKH B HERRNRING C DRESOW B KOHLSCHUTTER B STOCKSCHLADER M KRUGER WH KOHLSCHUTTER A ZANDER AR
Citation: M. Durken et al., NONTRANSFERRIN-BOUND IRON IN SERUM OF PATIENTS RECEIVING BONE-MARROW TRANSPLANTS, Free radical biology & medicine, 22(7), 1997, pp. 1159-1163
EXPRESSION OF FLT4 AND ITS LIGAND VEGF-C IN ACUTE MYELOID-LEUKEMIA
Authors: FIELDER W GRAEVEN U ERGUN S VERAGO S KILIC N STOCKSCHLADER M HOSSFELD DK
Citation: W. Fielder et al., EXPRESSION OF FLT4 AND ITS LIGAND VEGF-C IN ACUTE MYELOID-LEUKEMIA, Leukemia, 11(8), 1997, pp. 1234-1237
MATCHED UNRELATED DONOR TRANSPLANT WITH A FIVEFOLD GVH PREVENTION - SINGLE-CENTER EXPERIENCE
Authors: ZANDER AR ZABELNIA T KROGER N KRUGER W STOCKSCHLADER M GRIMM J KABISCH H ERTTMANN R
Citation: Ar. Zander et al., MATCHED UNRELATED DONOR TRANSPLANT WITH A FIVEFOLD GVH PREVENTION - SINGLE-CENTER EXPERIENCE, Experimental hematology, 25(8), 1997, pp. 324-324
CONDITIONING WITH BUSULFAN, ETOPOSIDE (VP16) AND CYCLOPHOSPHAMIDE IN AML IN FIRST REMISSION
Authors: ZANDER AR BERGER C KROGER N SCHONROCK P KRUGER W STOCKSCHLADER M BIELING P KABISCH H FIEDLER W DEWIT M HUTTMANN A GRIMM J ERTTMANN R KUSE R
Citation: Ar. Zander et al., CONDITIONING WITH BUSULFAN, ETOPOSIDE (VP16) AND CYCLOPHOSPHAMIDE IN AML IN FIRST REMISSION, Experimental hematology, 25(8), 1997, pp. 480-480
FACTORS INFLUENCING THE HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE
Authors: HASSAN HT KROG C STOCKSCHLADER M SCHLEIMER B ZELLER W KRUGER W ERTTMANN R ZANDER AR
Citation: Ht. Hassan et al., FACTORS INFLUENCING THE HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE, Anticancer research, 17(1B), 1997, pp. 589-599
AMPHOTROPIC MURINE LEUKEMIA VIRUSES INDUCE SPONGIFORM ENCEPHALOMYELOPATHY
Authors: MUNK C LOHLER J PRASSOLOV V JUST U STOCKSCHLADER M STOCKING C
Citation: C. Munk et al., AMPHOTROPIC MURINE LEUKEMIA VIRUSES INDUCE SPONGIFORM ENCEPHALOMYELOPATHY, Proceedings of the National Academy of Sciences of the United Statesof America, 94(11), 1997, pp. 5837-5842
LONG-TERM FOLLOW-UP OF LEUKEMIA PATIENTS AFTER RELATED CRYOPRESERVED ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: STOCKSCHLADER M HASSAN HT KROG C KRUGER W LOLIGER C HORSTMAN M ALTNODER M CLAUSEN J GRIMM J KABISCH H ZANDER A
Citation: M. Stockschlader et al., LONG-TERM FOLLOW-UP OF LEUKEMIA PATIENTS AFTER RELATED CRYOPRESERVED ALLOGENEIC BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 96(2), 1997, pp. 382-386
RETROVIRAL TRANSFER OF A TRUNCATED VERSION OF THE LOW-AFFINITY NERVE GROWTH-FACTOR RECEPTOR (DELTA-LNGFR) INTO HEMATOPOIETIC PROGENITOR CELLS (CD34(-TERM EXPRESSION OF THE TRANSGENE()) ALLOWS THE ANALYSIS OF THE LONG)
Authors: FEHSE B UHDE A FEHSE N ECKERT HG RUGER R KOCH S OSTERTAG W ZANDER AR STOCKSCHLADER M
Citation: B. Fehse et al., RETROVIRAL TRANSFER OF A TRUNCATED VERSION OF THE LOW-AFFINITY NERVE GROWTH-FACTOR RECEPTOR (DELTA-LNGFR) INTO HEMATOPOIETIC PROGENITOR CELLS (CD34(-TERM EXPRESSION OF THE TRANSGENE()) ALLOWS THE ANALYSIS OF THE LONG), Blood, 90(10), 1997, pp. 4600-4600
USE OF A SURFACE MARKER GENE (DELTA-LNGFR) FOR THE DEVELOPMENT OF NEWPROTOCOLS FOR THE EFFICIENT TRANSDUCTION OF HUMAN T-LYMPHOCYTES WITH RETROVIRAL VECTORS
Authors: SCHADE U LI ZX FEHSE B UHDE A KOCH S GOLLER B RUGER R FEHSE N STOCKSCHLADER M ZANDER AR
Citation: U. Schade et al., USE OF A SURFACE MARKER GENE (DELTA-LNGFR) FOR THE DEVELOPMENT OF NEWPROTOCOLS FOR THE EFFICIENT TRANSDUCTION OF HUMAN T-LYMPHOCYTES WITH RETROVIRAL VECTORS, Blood, 90(10), 1997, pp. 4628-4628
FIBRONECTIN ENHANCES RETROVIRAL TRANSDUCTION OF PRIMARY HUMAN T-LYMPHOCYTES
Authors: STOCKSCHLADER M HAISS M EXNER S FEHSE B SCHADE U ZANDER A RUGER R KOCH S ROSENTHAL F VONKALLE C MERTELSMANN R FINKE J
Citation: M. Stockschlader et al., FIBRONECTIN ENHANCES RETROVIRAL TRANSDUCTION OF PRIMARY HUMAN T-LYMPHOCYTES, Blood, 90(10), 1997, pp. 2472-2472
VASCULAR ENDOTHELIAL GROWTH-FACTOR, A POSSIBLE PARACRINE GROWTH-FACTOR IN HUMAN ACUTE MYELOID-LEUKEMIA
Authors: FIEDLER W GRAEVEN U ERGUN S VERAGO S KILIC N STOCKSCHLADER M HOSSFELD DK
Citation: W. Fiedler et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR, A POSSIBLE PARACRINE GROWTH-FACTOR IN HUMAN ACUTE MYELOID-LEUKEMIA, Blood, 89(6), 1997, pp. 1870-1875
COMPARISON BETWEEN BONE-MARROW AND G-CSF-MOBILIZED PERIPHERAL-BLOOD ALLOGRAFTS UNDERGOING CLINICAL-SCALE CD34(+) CELL SELECTION
Authors: HASSAN HT ZELLER W STOCKSCHLADER M KRUGER W HOFFKNECHT MM ZANDER AR
Citation: Ht. Hassan et al., COMPARISON BETWEEN BONE-MARROW AND G-CSF-MOBILIZED PERIPHERAL-BLOOD ALLOGRAFTS UNDERGOING CLINICAL-SCALE CD34(+) CELL SELECTION, Stem cells, 14(4), 1996, pp. 419-429
PHILADELPHIA-CHROMOSOME-POSITIVE SECONDARY ACUTE MYELOID-LEUKEMIA FOLLOWING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: STOCKSCHLADER M FIEDLER W ZANDER A WEH HJ HOSSFELD DK
Citation: M. Stockschlader et al., PHILADELPHIA-CHROMOSOME-POSITIVE SECONDARY ACUTE MYELOID-LEUKEMIA FOLLOWING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA, Annals of hematology, 73(6), 1996, pp. 291-293
Risultati: 1-25 | 26-50 | 51-69